VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 187 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,114,331 | -43.9% | 257,947 | -14.4% | 0.00% | -57.1% |
Q2 2023 | $1,985,112 | -7.3% | 301,231 | -4.5% | 0.01% | -78.1% |
Q1 2023 | $2,141,356 | +97.1% | 315,369 | +114.5% | 0.03% | +60.0% |
Q4 2022 | $1,086,626 | -48.6% | 147,040 | -24.3% | 0.02% | -65.5% |
Q2 2022 | $2,116,000 | +192.3% | 194,164 | +203.1% | 0.06% | +205.3% |
Q1 2022 | $724,000 | -57.5% | 64,050 | -41.0% | 0.02% | -64.2% |
Q4 2021 | $1,702,000 | – | 108,491 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |